Parida Shreemanta K

• Clinician scientist with international experiences in the field of Vaccines, Infectious Diseases, Epidemiology, Therapeutic Immunology, ATMP Cell Therapy, Oncology, Translational & Precision Medicine, Global Health, TB, and Biomarkers • ICH-GCP driven clinical trials (Phase I-III) experience as leader, responsible for strategic planning, scientific and clinical operations, team building, project management and partnership development (Adjunctive autologous MSC clinical development for drug-resistant Tuberculosis as Lead of the Clinical Trial; KI, GC6-74 TB Biomarkers; MPIIB), Innovation in Biotech industries • Extensive experience in scientific communication, innovative program planning, medical and regualtory affairs, product development, biotech, GMP manufacturing, mentoring, monitoring & evaluation, public speaking, negotiating as well as capacity building • Leadership and management skills embracing large multidisciplinary multi-cultural groups (AHRI; MPIIB: GC6, DBT); Skilled portfolio management across matrices • Focus on translating cross-cutting scientific advances to patient care in clinics through clinical development pathway to licensure (NII: Leprosy vaccine – Leprovac; MPIIB/BMGF: TB Biomarkers: Still a Flagship Project; DBT/VGCP: Rotavirus and Typhoid vaccine for approval; KI: MSC therapy for DR-TB; Zellwerk: TIL, NK, MSC therapy; UNVC: Viral Vaccine & Biotherapeutics Clin Dev)